SAN DIEGO, Feb. 14, 2011 /PRNewswire/ — Volcano Corporation
(Nasdaq:
VOLC), a leading developer and manufacturer of precision
intravascular therapy guidance tools designed to enhance the
diagnosis and treatment of coronary and peripheral vascular
disease, today announced that it will report its operating results
for the fourth quarter and all of fiscal 2010 on Wednesday,
February 23.
The company will hold a conference call to discuss its financial
results and operating activities open to all interested parties at
2 p.m., Pacific Standard Time, (5 p.m., Eastern Standard Time),
Wednesday, February 23, hosted by Scott Huennekens, president and
chief executive officer, and John Dahldorf, chief financial
officer.
The teleconference can be accessed by calling (631) 291-4555,
passcode 38609287. Please dial in 10-15 minutes prior to the
beginning of the call. The webcast will be available through the
company’s website at www.volcanocorp.com.
A replay of the conference call will be available through
Wednesday, March 2, at (706) 645-9291, passcode 38609287, and via
the company’s website.
About Volcano Corporation
Volcano Corporation (NASDAQ:
VOLC) is revolutionizing the medical device industry with a
broad suite of technologies that make imaging and therapy simpler,
more informative and less invasive. Our products empower physicians
around the world with a new generation of analytical tools that
deliver more meaningful information—using sound and light as
the guiding elements. Founded in cardiovascular care and expanding
into other specialties, Volcano is changing the assumption about
what is possible in improving patient outcomes by combining imaging
and therapy together. For more information, visit the company’s
website at ‘/>”/>
